Baroda BNP Paribas Value Fund
Direct Plan · Growth Option · Baroda BNP Paribas Mutual Fund
Returns
Annualised (CAGR) returns for periods over a year.
Want to invest in this fund?
Open a free demat & trading account with Zerodha to invest in direct mutual funds with zero commission.
Rank in Category
| Period | This Fund | Category Avg. | Rank |
|---|---|---|---|
| 1W | -0.23% | -0.15% | 15 of 24 |
| 1M | -4.04% | -4.08% | 9 of 23 |
| 3M | -3.60% | -4.44% | 8 of 22 |
| 6M | +2.43% | +5.27% | 16 of 22 |
| YTD | -7.06% | -5.61% | 13 of 24 |
| 1Y | -4.12% | -2.57% | 13 of 22 |
| 2Y | -4.52% | -2.39% | 16 of 21 |
| 3Y | +8.14% | +10.01% | 18 of 21 |
| INCEPTION | +9.77% | — | — |
Ranked among: Equity Scheme - Value Fund.
Rolling Returns
| Period | Average | Best | Worst | Positive Periods | Consistency |
|---|---|---|---|---|---|
| 3M | +2.86% | +25.05% | -14.18% | 64% | 25% |
| 6M | +5.80% | +31.46% | -18.92% | 65% | 26% |
| 1Y | +9.61% | +48.79% | -11.50% | 63% | 26% |
| 2Y | +6.60% | +19.81% | -6.84% | 72% | 30% |
| 3Y | +10.55% | +12.80% | +7.82% | 100% | 44% |
Rolling returns show the average, best and worst outcome an investor would have seen entering at any point in the window.
NAV History
AUM Trend (₹ Cr, quarterly average)
Expense Ratio Trend
Portfolio · Aug 2026
Asset Allocation
- Equity94.16%
- Debt0.49%
- Cash0.27%
- Other5.08%
Market Cap Split
- Large Cap65.60%
- Mid Cap19.04%
- Small Cap9.49%
- Others5.87%
Fundamentals
| Fund | Category | |
|---|---|---|
| P/E | 22.67 | 20.82 |
| P/B | 3.29 | 2.82 |
| Price / Sales | 3.27 | 2.28 |
| Price / Cash Flow | 17.82 | 14.35 |
| Dividend Yield (%) | 1.61 | 1.68 |
Holdings · Aug 2026
| Holding | Sector | Weight | Change (1M) |
|---|---|---|---|
| ICICI Bank | Banks | 5.27% | +0.17% |
| Reliance Industries | Petroleum Products | 5.14% | -1.70% |
| HDFC Bank | Banks | 5.01% | -0.17% |
| Bharat Heavy Electricals | Electrical Equipment | 4.46% | -0.24% |
| Larsen & Toubro | Construction | 3.87% | -0.15% |
| Divis Laboratories | Pharmaceuticals & Biotechnology | 3.81% | +0.23% |
| GE Vernova T&D | Electrical Equipment | 3.81% | -0.45% |
| Sun Pharmaceutical | Pharmaceuticals & Biotechnology | 2.70% | +0.05% |
| Torrent Pharmaceuticals | Pharmaceuticals & Biotechnology | 2.58% | +0.03% |
| Infosys | IT - Software | 2.57% | +0.06% |
| State Bank of India | Banks | 2.40% | +0.12% |
| Tech Mahindra | IT - Software | 2.36% | +0.01% |
| Hindustan Zinc | Non - Ferrous Metals | 2.27% | +0.26% |
| NHPC | Power | 1.95% | -0.01% |
| Eicher Motors | Automobiles | 1.95% | +0.07% |
View all 53 holdings
| Oil India | Oil | 1.95% | -0.09% |
| Bharat Electronics | Aerospace & Defense | 1.88% | +0.16% |
| Power Grid Corporation of India | Power | 1.84% | -0.10% |
| Zydus Life Science | Pharmaceuticals & Biotechnology | 1.75% | -0.25% |
| Vedanta Aluminium Metal | Non - Ferrous Metals | 1.74% | -0.03% |
| Tenneco Clean Air | Auto Components | 1.70% | +0.51% |
| Hero Motocorp | Automobiles | 1.65% | -0.74% |
| UltraTech Cement | Cement & Cement Products | 1.61% | -0.19% |
| NALCO | Non - Ferrous Metals | 1.59% | +0.16% |
| Jtekt | Auto Components | 1.55% | -0.16% |
| MCX | Capital Markets | 1.54% | +0.35% |
| Tata Motors | Agricultural, Commercial & Construction Vehicles | 1.49% | +0.13% |
| Maruti Suzuki | Automobiles | 1.47% | -0.05% |
| ITC | Diversified FMCG | 1.39% | -0.11% |
| Yes Bank | Banks | 1.32% | +0.03% |
| LG Electronics | Consumer Durables | 1.31% | +0.19% |
| India Cements | Cement & Cement Products | 1.29% | -0.07% |
| Tata Power | Power | 1.26% | -0.09% |
| Hindustan Unilever | Diversified FMCG | 1.25% | -0.06% |
| Indusind Bank | Banks | 1.20% | +0.03% |
| HDFC Life Insurance | Insurance | 1.18% | +0.01% |
| Axis Bank | Banks | 1.18% | +0.09% |
| Trent | Retailing | 1.16% | +0.27% |
| Tata Consultancy Services | IT - Software | 1.09% | -1.01% |
| Sanofi Consumer Healthcare | Pharmaceuticals & Biotechnology | 1.08% | -0.10% |
| Canara Bank | Banks | 1.04% | +0.04% |
| JSW Dulux | Consumer Durables | 1.00% | +0.09% |
| Coal India | Consumable Fuels | 0.98% | -0.01% |
| Mahanagar Gas | Gas | 0.97% | -0.02% |
| Alkem Laboratories | Pharmaceuticals & Biotechnology | 0.97% | -0.05% |
| KPIT Technologies | IT - Software | 0.95% | +0.00% |
| Brigade Enterprises | Realty | 0.83% | — |
| LIC of India | Insurance | 0.65% | — |
| 364TB40227 | Money Market | 0.49% | +0.01% |
| Net Receivables / (Payables) | Net Current Assets | 0.27% | — |
| Birlasoft | IT - Software | 0.11% | -0.78% |
| Symbiotec Pharmalab | Pharmaceuticals & Biotechnology | 0.03% | — |
| Sundaram Clayton | Auto Components | 0.01% | -0.06% |
Sector Allocation · Aug 2026
View all 22 sectors
Risk Metrics
Standard Deviation
| Period | Fund | Category | |
|---|---|---|---|
| 1Y | 14.17 | 18.12 | Low Volatility |
| 3Y | 15.55 | 16.05 | Low Volatility |
What is this?
Risk as measured by standard deviation is a statistical measure that quantifies the amount of variation or dispersion in a set of data points relative to its mean (average).
Sharpe Ratio
| Period | Fund | Category | |
|---|---|---|---|
| 1Y | -0.38 | -0.24 | Poor Risk Adjusted Returns |
| 3Y | 0.18 | 0.32 | Poor Risk Adjusted Returns |
What is this?
Higher the value means that fund has been able to give better returns for the amount of risk taken. It helps investors understand the return of an investment compared to its risk, showing whether the returns are due to intelligent investing or simply taking on excess risk. It is calculated by subtracting the risk-free return, defined as an Indian Government Bond, from the fund's returns, and then dividing by the standard deviation of returns.
Sortino Ratio
| Period | Fund | Category | |
|---|---|---|---|
| 1Y | -0.49 | -0.26 | Poor Risk Adjusted Returns |
| 3Y | 0.27 | 0.48 | Poor Risk Adjusted Returns |
What is this?
The Sortino Ratio is a financial metric used to measure the risk-adjusted return of an investment. It's a modification of the Sharpe Ratio but with a key difference; it only considers downside risk (the risk of negative returns), rather than total volatility. This means it focuses on how well an investment performs relative to the volatility that leads to losses, ignoring the volatility that results in gains. The idea is that investors are primarily concerned with minimizing losses, and positive volatility is generally seen as a good thing.
Beta
| Period | Fund | Category | |
|---|---|---|---|
| 1Y | 0.90 | 0.94 | Good Risk Adjusted Returns |
| 3Y | 0.96 | 0.97 | Good Risk Adjusted Returns |
What is this?
This value gives idea about how volatile fund performance has been compared to similar funds in the market. Lower beta implies the fund gives more predictable performance compared to similar funds in the market.
Compare With Peers
| Scheme | 1Y | 3Y | 5Y | Since Inception |
|---|---|---|---|---|
|
LIC MF Value Fund
Direct Plan · IDCW
|
+19.34% | +16.99% | — | +17.04% |
|
Quant Value Fund
Direct Plan · Growth Option
|
+12.11% | +19.76% | — | +18.93% |
|
Mahindra Manulife Value Fund
Regular Plan · IDCW
|
+4.62% | — | — | +11.07% |
|
HDFC Value Fund
Regular Plan · Growth Option
|
+2.78% | +14.05% | +11.83% | +13.09% |
|
DSP Value Fund
Regular Plan · Growth
|
+2.58% | +14.75% | +11.61% | +15.28% |
|
Aditya Birla Sun Life Value Fund
Regular Plan · IDCW
|
-0.27% | +4.57% | +4.70% | +7.90% |
|
HSBC Value Fund
Regular Plan · Growth
|
-0.60% | +13.46% | — | +16.28% |
|
Groww Value Fund
Direct Plan · Growth
|
-1.24% | +11.57% | +10.64% | +11.09% |
|
JM Value Fund
Regular Plan · Growth Option
|
-2.13% | +10.37% | +12.87% | +8.59% |
|
Tata Value Fund
Regular Plan · Growth Option
|
-3.05% | +11.20% | +11.24% | +13.96% |
More From Baroda BNP Paribas Asset Management India Private Limited
| Scheme | 1Y | 3Y | 5Y | Since Inception |
|---|---|---|---|---|
|
Baroda BNP Paribas Gold ETF
Regular Plan · Growth Option
|
+21.90% | — | — | +34.44% |
|
Baroda BNP Paribas Gold ETF Fund of Fund
Direct Plan · Growth Option
|
+20.62% | — | — | +38.89% |
|
Baroda BNP Paribas Health and Wellness Fund
Direct Plan · IDCW Option
|
+9.94% | — | — | +4.80% |
|
Baroda BNP Paribas Aqua Fund of Fund
Direct Plan · IDCW Option
|
+9.86% | +16.60% | — | +12.24% |
|
Baroda BNP Paribas Innovation Fund
Direct Plan · IDCW Option
|
+9.21% | — | — | +13.28% |
|
Baroda BNP Paribas Small Cap Fund
Direct Plan · IDCW Option
|
+9.11% | — | — | +12.59% |
|
Baroda BNP Paribas Manufacturing Fund
Direct Plan · IDCW Option
|
+8.52% | — | — | +3.44% |
|
Baroda BNP Paribas Credit Risk Fund (scheme has Two segregated portfolios)
Direct Plan · Growth Option
|
+7.05% | +8.36% | +9.33% | +8.73% |
|
Baroda BNP Paribas Multi Asset Active Fund of Funds
Direct Plan · Growth Option
|
+6.65% | — | — | +9.53% |
|
Baroda BNP Paribas Ultra Short Term Fund
Direct Plan · Growth Option
|
+6.58% | +7.22% | +6.70% | +6.52% |
About This Scheme
Investment Objective
The investment objective of the scheme is to generate long-term capital appreciation from a diversified portfolio of predominantly equity and equity related instruments by following a value investment strategy. However, there can be no assurance that the investment objectives of the Scheme will be realized. The Scheme does not guarantee/indicate any returns.
Stated Asset Allocation
Equity and Equity related instruments: 80 - 100% Money Market and other liquid instruments*, Gold and Silver instruments (through ETFs): 0 - 35% Units issued by INvITs: 0 - 10% Units of Mutual Funds as permitted by SEBI$: 0 - 10%
Exit Load
1. If units of the scheme are redeemed or switched out up to 10% of the units (the limit) within 1 year from the date of allotment - Nil. 2. If units of the scheme are redeemed or switched out in excess of the limit within 1 year from the date of allotment - 1% of the applicable NAV. 3. If units of scheme are redeemed or switched out after 1 year from the date of allotment - Nil.
Fund Managers
Mr. Rohan Korde, Mr. Ankeet Pandya
Mr. Rohan Korde (Primary Fund Manager), Mr. Ankeet Pandya (Primary Fund Manager)
Mutual fund investments are subject to market risks. Read all scheme related documents carefully. Past performance is not indicative of future returns. Data is sourced from AMFI and fund houses via FinAPI and may lag official figures.
GMP IPO Watch